Grupo de Investigación

Calleja Panero, Jose Luis - GCV13/EHD/1

» Institución
Servicio Madrileño de Salud

» Centro
HOSPITAL UNIVERSITARIO PUERTA DE HIERRO

» Contacto
Calle Joaquín Rodrigo
28220 - Majadahonda | MADRID
Tel.

Apellido, Nombre	Modalidad	Detalle
Calleja Panero, Jose Luis	Jefe de Grupo	VER FICHA
de la Revilla Negro, Juan	Adscrito	VER FICHA
Fernández Carrillo, Carlos	Adscrito	VER FICHA
Llop Herrera, Elba	Adscrito	VER FICHA
Martínez Porras, José Luís	Adscrito	VER FICHA
Pons Renedo, Fernando	Adscrito	VER FICHA
TRAPERO MARUGAN, MARIA	Adscrito	VER FICHA

Las 10 primeras publicaciones según Factor de impacto (F.I.) de los últimos 4 años:

Calleja J.L., Aguilera A., Buti M., Crespo J., Garcia F., Jorquera F. et al. Ten steps to eliminating hepatitis C in hospitals. Nature Reviews Gastroenterology and Hepatology. 2022;19(8):481-483.
PUBMED DOI
Lazarus J.V., Mark H.E., Anstee Q.M., Arab J.P., Batterham R.L., Castera L. et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nature Reviews Gastroenterology and Hepatology. 2022;19(1):60-78.
PUBMED DOI
Lin H., Lee H.W., Yip T.C.-F., Tsochatzis E., Petta S., Bugianesi E. et al. Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease. JAMA. 2024;331(15):1287-1297.
PUBMED DOI
Crespo J., Cabezas J., Calleja J.L., Buti M., Lazarus J.V.The path to successful hepatitis C elimination in Spain. Nature Reviews Gastroenterology and Hepatology. 2023;20(11):689-690.
PUBMED DOI
Jachs M., Odriozola A., Turon F., Moga L., Tellez L., Fischer P. et al. Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study. The Lancet Gastroenterology and Hepatology. 2024;.
PUBMED DOI
Balcar L., Mandorfer M., Hernandez-Gea V., Procopet B., Meyer E.L., Giraldez A. et al. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding. Journal of Hepatology. 2024;.
PUBMED DOI
Magaz M., Giudicelli-Lett H., Abraldes J.G., Nicoara-Farcau O., Turon F., Rajoriya N. et al. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome. Journal of Hepatology. 2024;.
PUBMED DOI
Dajti E., Villanueva C., Berzigotti A., Brujats A., Albillos A., Genesca J. et al. Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial. Journal of Hepatology. 2024;.
PUBMED DOI
Baiges A., Procopet B., Silva-Junior G., Llop E., Tellez L., Darnell A. et al. Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis. Journal of Hepatology. 2023;78(1):114-122.
PUBMED DOI
Chun H.S., Papatheodoridis G.V., Lee M., Lee H.A., Kim Y.H., Kim S.H. et al. PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B. Journal of Hepatology. 2024;80(1):20-30.
PUBMED DOI